Stryker Ramps Up Compliance Spending, But Predicts Unimpeded Growth

Stryker is raising its stake in compliance activities in response to government scrutiny of its regulatory and sales practices, but the firm does not foresee a major hit to its bottom line

More from Archive

More from Medtech Insight